Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

622 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
SYK expression level distinguishes control from BRCA1-mutated lymphocytes.
Zahavi T, Sonnenblick A, Shimshon Y, Kadouri L, Peretz T, Salmon AY, Salmon-Divon M. Zahavi T, et al. Among authors: salmon ay, salmon divon m. Cancer Manag Res. 2018 Mar 26;10:589-598. doi: 10.2147/CMAR.S156359. eCollection 2018. Cancer Manag Res. 2018. PMID: 29618939 Free PMC article.
[Tumor, metastasis and what's in between].
Grinshpun A, Ben-Porath I, Peretz T, Salmon A. Grinshpun A, et al. Among authors: salmon a. Harefuah. 2013 Jan;152(1):30-3, 59, 58. Harefuah. 2013. PMID: 23461025 Review. Hebrew.
p-STAT3 in luminal breast cancer: Integrated RNA-protein pooled analysis and results from the BIG 2-98 phase III trial.
Sonnenblick A, Salgado R, Brohée S, Zahavi T, Peretz T, Van den Eynden G, Rouas G, Salmon A, Francis PA, Di Leo A, Crown JPA, Viale G, Daly L, Javdan B, Fujisawa S, De Azambuja E, Lieveke A, Piccart MJ, Bromberg JF, Sotiriou C. Sonnenblick A, et al. Among authors: salmon a. Int J Oncol. 2018 Feb;52(2):424-432. doi: 10.3892/ijo.2017.4212. Epub 2017 Nov 27. Int J Oncol. 2018. PMID: 29207087 Free PMC article. Clinical Trial.
Heparanase: a potential marker of worse prognosis in estrogen receptor-positive breast cancer.
Zahavi T, Salmon-Divon M, Salgado R, Elkin M, Hermano E, Rubinstein AM, Francis PA, Di Leo A, Viale G, de Azambuja E, Ameye L, Sotiriou C, Salmon A, Kravchenko-Balasha N, Sonnenblick A. Zahavi T, et al. Among authors: salmon divon m, salmon a. NPJ Breast Cancer. 2021 May 28;7(1):67. doi: 10.1038/s41523-021-00277-x. NPJ Breast Cancer. 2021. PMID: 34050190 Free PMC article.
Reactive stroma and trastuzumab resistance in HER2-positive early breast cancer.
Sonnenblick A, Salmon-Divon M, Salgado R, Dvash E, Pondé N, Zahavi T, Salmon A, Loibl S, Denkert C, Joensuu H, Ameye L, Van den Eynden G, Kellokumpu-Lehtinen PL, Azaria A, Loi S, Michiels S, Richard F, Sotiriou C. Sonnenblick A, et al. Among authors: salmon divon m, salmon a. Int J Cancer. 2020 Jul 1;147(1):266-276. doi: 10.1002/ijc.32859. Epub 2020 Jan 22. Int J Cancer. 2020. PMID: 31904863
622 results